Author

Jasmine Kaur

Cooper Medical School of Rowan UniversityPrimary ORCID profile (0000-0002-9458-2157 · 1 paper)Unclaimed ORCID profile · follow to get notified of new preprints

Listed by name: these papers carry no ORCID for this author, so different people with the same name may be mixed together.

Same name, identified by ORCID

Jasmine KauriD1 paper · ETH Zurich

Biology Disciplines

Click to filter author papers

Cancer Biology· 1 Cell Biology· 1

Signature Assays, Organisms & Methods

Click to filter · or open tag

Approach:experimental assay· 2 Research Focus:cancer & tumor microenvironment· 1 Organism:human· 1 Organism:mouse· 1 Assay:proteomics· 1

Frequent Co-Authors

Anjali Mange· 1 shared Ariana Machado· 1 shared Arvind IngleiD· 1 shared Ashish Shingade· 1 shared Ashok Dudhalkar· 1 shared Darren F. BoehningiD· 1 shared Ghanapriya YengkhomiD· 1 shared Mahesh GoeliD· 1 shared

Activity by Year

2026-2026 · peak 2/yr

Co-Author Collaboration Network

10 top collaborators · 24 mutual co-author links

Click any collaborator node to inspect or filter shared papers

Focal author (center)Selected co-authorORCID co-authorUnlinked name

Curved chords = mutual co-authorship

1 shared paperCancer Biology

Anjali Mange

Mutual co-authors in cluster

Author profile →

2 papers

Recent·Most cited

Estrogen is Coupled to the Calcium Release Machinery in HumanLeiomyoma Cells

Ariana Machado, Jasmine Kaur, Veronica Kan, Ying Fan, Mostafa A. Borahay, Darren F. Boehning

This study shows estrogen promotes leiomyoma growth by activating GPR30, which triggers calcium release, and blocking this pathway reduces tumor proliferation.

bioRxiv · Sep 23, 2026 · PreprintCell Biology

Occurrence of Biased mTOR Signaling in Hepatocellular Carcinoma

Rudransh Singh, Niriksha Patel, Neha Singh, Pooja Mourya, Ashish Shingade, Anjali Mange, Jasmine Kaur, Sakshi Beloshe, Ashok Dudhalkar, P. Chavan, Ghanapriya Yengkhom, Shraddha Patkar, Mahesh Goel, Arvind Ingle, Sagar Ranjan Tripathy, , Sunil Shetty

This study identifies biased mTOR signaling in hepatocellular carcinoma (HCC) and shows that dual inhibition of mTORC1 and mTORC2 significantly reduces HCC progression.

bioRxiv · Jul 26, 2026 · PreprintCancer Biology